Timothy M. Uyeki, M.D., M.P.H., M.P.P. NEJM Volume 362:2221-2223 June 10, 2010 Number 23. Related Article by Lee, V. J. & Related Article by Cowling, B. J.
The emergence of 2009 pandemic influenza A (H1N1) virus prompted early questions about how the virus was spreading and how easily it was transmitted, along with uncertainty about disease severity, clinical complications and risk factors for severe disease, and the effectiveness of antiviral treatment and control measures.
Without a vaccine against the 2009 H1N1 virus, early control measures included both pharmaceutical interventions (the use of antiviral agents) and nonpharmaceutical interventions (e.g., school closures, isolation, and quarantine), depending on the specific outbreak setting, available resources, and goals. The use of these interventions varied according to country and the evolution of the . . . [Full Text of this Article]
Weblink here
